Supplements to Aid Sleep
Primary Recommendation
For adults with sleep difficulties, melatonin 3 mg taken 1.5-2 hours before bedtime is the most evidence-based supplement option, though its effects are modest—reducing sleep onset by approximately 9 minutes with minimal impact on sleep maintenance. 1, 2
Evidence-Based Supplement Options
Melatonin: The Only Supplement with Guideline Support
Dosing Strategy:
- Start with 3 mg of immediate-release melatonin administered 1.5-2 hours before desired bedtime 2
- If ineffective after 1-2 weeks, increase by 3 mg increments up to a maximum of 15 mg 2
- Lower doses (3 mg) are often more effective than higher doses (10 mg) due to receptor saturation and desensitization at higher doses 2
Expected Benefits:
- Reduces sleep onset latency by 9 minutes compared to placebo 1
- Minimal effect on total sleep time or sleep maintenance 1
- Most effective for circadian rhythm disorders (delayed sleep phase, jet lag) rather than primary insomnia 1, 3
Important Limitations:
- The American Academy of Sleep Medicine suggests clinicians NOT use melatonin as a treatment for sleep onset or sleep maintenance insomnia in adults, based on weak evidence 1
- Long-term use beyond 3-4 months is not recommended due to insufficient safety data 2
- Effects are modest and variable across individuals 4, 5
Critical Safety Considerations
Product Quality Concerns:
- Melatonin is regulated as a dietary supplement in the U.S., raising significant concerns about purity and reliability of stated doses 2
- Choose United States Pharmacopeial Convention (USP) Verified formulations for more reliable dosing 2
Contraindications and Precautions:
- Use with caution in patients taking warfarin due to potential interactions 2
- Exercise caution in patients with epilepsy based on case reports 2
- Avoid in older adults with dementia—detrimental effects on mood and daytime functioning have been observed 2
- May cause vivid dreams/nightmares, particularly at higher doses 6
- Associated with impaired glucose tolerance in some individuals 2
Common Adverse Effects:
- Morning grogginess and "hangover" effects, especially with higher doses 2
- Headache (0.74% of patients) 2
- Dizziness (0.74% of patients) 2
- Gastrointestinal upset at higher doses 2
Other Supplements: Insufficient Evidence
Diphenhydramine:
- The American Academy of Sleep Medicine found no clinically significant improvement in sleep efficiency or quality 1
- Not recommended for insomnia treatment 1
Vitamin B12:
Superior Non-Supplement Approaches
First-Line Treatment:
- Cognitive Behavioral Therapy for Insomnia (CBT-I) should be offered as first-line treatment when available 3
- Multiple studies demonstrate superior efficacy compared to supplements 1
Sleep Hygiene (Essential Foundation):
- Maintain stable bedtimes and rising times—arise at the same time each morning regardless of sleep obtained 1
- Avoid caffeine, nicotine, and alcohol, particularly after 2:00 PM 1, 2
- Avoid heavy exercise within 2 hours of bedtime 1
- Use bedroom only for sleep and sex—no television or work in bed 1
- If unable to fall asleep within 20 minutes, leave the bedroom and return only when sleepy 1
- Limit daytime napping to 30 minutes before 2:00 PM 1
Physical Activity:
- Regular morning or afternoon exercise improves sleep quality 1
- Yoga interventions have shown improvements in sleep quality and efficiency in cancer survivors 1
- Walking, Tai Chi, and weight training may improve sleep, though mechanisms are not well understood 1
Clinical Decision Algorithm
- Assess for underlying causes: Sleep apnea, restless legs syndrome, medication effects, psychiatric conditions 1
- Implement sleep hygiene measures first (see above) 1
- Consider CBT-I as first-line treatment if available 3
- If supplement requested: Melatonin 3 mg, 1.5-2 hours before bedtime, USP-verified formulation 2
- Reassess after 1-2 weeks: If ineffective, increase by 3 mg increments (maximum 15 mg) 2
- Limit duration: Use for maximum 3-4 months, with periodic reassessment every 3-6 months 2
- If ineffective or adverse effects occur: Discontinue and refer for comprehensive sleep evaluation 1
Common Pitfalls to Avoid
- Do not recommend melatonin as a primary treatment for chronic insomnia—evidence shows minimal benefit 1, 3
- Do not start with high doses (10 mg)—lower doses are more effective and better tolerated 2
- Do not use melatonin in older adults with dementia—risk of harm outweighs potential benefits 2
- Do not assume all melatonin products are equivalent—quality varies significantly without USP verification 2
- Do not neglect sleep hygiene education—supplements alone are insufficient 1